AGP Executive Report
Last update: 12 hours agoEbola Response: WHO chief says people in DR Congo can recover from Ebola and urges treatment at designated facilities as the outbreak expands, while China sends medical expert teams to support control efforts. Hepatitis B Breakthrough: A first-of-its-kind hepatitis B drug reported “functional cure” results in international studies, letting some patients stop treatment without dangerous virus rebound. Neurodegeneration Focus: China steps up Alzheimer’s and Parkinson’s drug development, including a push to integrate TCM approaches. Cancer & Biotech Deals: Haisco signs a $3B+ R&D agreement with Eli Lilly; Pfizer and Innovent also announce a major $10.5B oncology collaboration, underscoring China’s accelerating biotech pipeline. Duchenne Update: Santhera’s AGAMREE gets orphan drug and priority review designations in South Korea for DMD. Organ Shortage Milestone: Surgeons report the first combined pig liver and kidney transplant into a brain-dead human recipient, aiming to tackle donor scarcity. Community Health: Jinan’s child-friendly parks and Changzhou’s intergenerational care model highlight practical, everyday wellness design.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
